Launch of ClearTrial 4.2 Offers New Levels of Integration, Interoperability, and Configurability
New ClearTrial Web Services API (Application Programming Interface) streamlines ClearTrial integration with existing systems; major new features enhance software's flexibility
CHICAGO, IL – DIA 47th Annual Meeting – June 20, 2011
ClearTrial today announced the launch of ClearTrial 4.2, an important release that introduces the ClearTrial Web Services API (Application Programming Interface). The ClearTrial Web Services API streamlines the integration of ClearTrial with any system that can utilize a Web Service – which encompasses virtually all of the eClinical, financial, resource management, and business intelligence systems in use by biopharmaceutical and medical device companies today.
"Our customers increasingly rely on ClearTrial software as a unifying platform and system of record for the planning, forecasting, and tracking of clinical projects, which ultimately requires the seamless flow of information between many other systems," noted Andrew Grygiel, Vice President of Marketing and Product Management for ClearTrial. "The new Web Services API makes the integration and interoperability of ClearTrial with their existing systems even faster and easier than before."
As just one example, the ClearTrial Web Services API can be used to automate the flow of data between ClearTrial software and a resource management system such as Oracle Primavera. This allows the resource management system, in assigning named resources to projects, to utilize the ClearTrial activity-based resource demand forecast – which has proven to be highly accurate in determining what types of resources will be required on a clinical project or program, and when. The result is a far more efficient utilization of resources across the project portfolio, avoiding the chronic over- and understaffing typical in the industry.
"There are many other examples where integrating ClearTrial software into existing systems will further compress study cycle-times, reduce costs, and improve study achievability," added Grygiel. "And to help our customers achieve these benefits more quickly, we will be building preconfigured connectors to leading systems in use today."
For more information on the ClearTrial Web Services API, visit http://www.cleartrial.com/products-and-services/cleartrial-web-services-api.
Enhanced flexibility, configurability, and accuracy
ClearTrial 4.2 also delivers several important features that provide greater flexibility and configurability in study planning, forecasting, outsourcing, and tracking. In addition, the new release offers expanded clinical intelligence and refined cost drivers, solidifying ClearTrial's position as the "gold standard" in accuracy – having been benchmarked to 95-99% accurate when comparing forecasted to actual costs.
The major new features of ClearTrial 4.2 include:
Meetings Manager – ClearTrial Meetings Manager provides a single interface to efficiently manage and track all required meetings through the life of a study. Users can create both recurring and one-off meetings of various types; choose the meeting attendees for each meeting and enter specific meeting details such as meeting attendance method and preparation time; track and override pass-through costs associated with meetings; and automatically generate new reports of meeting-related assumptions, labor fees and pass-through costs.
EDC Maturity Model – ClearTrial software has been enhanced to more accurately calculate Electronic Data Capture (EDC) labor fees and pass-through costs by leveraging a configurable EDC Maturity Model. This enhancement is based on extensive industry research into the differing stages of EDC deployment in the industry, ranging from limited deployment and experience with EDC, to complete enterprise deployment of EDC.
Reporting Regions – ClearTrial 4.2 further advances the configurability of the software to reflect business processes by enabling the creation of user-defined regions for reporting purposes. An organization can easily map countries to reporting regions and use this grouping to roll-up labor fees and costs in financial reports such as the Monthly Budget.
Expanded industry intelligence – ClearTrial 4.2 has been enhanced to support 47 new indications across several therapeutic areas. ClearTrial now supports more than 200 therapeutic indications, with algorithms derived from a careful analysis of the cost and time drivers that affect each study task specifically for that indication.
"ClearTrial 4.2 demonstrates ClearTrial's commitment to clinical software excellence, as measured by how well ClearTrial serves our customers' needs," concluded Grygiel. "The latest release of our award-winning software delivers on this promise with a comprehensive set of capabilities to greatly improve the efficiency of clinical development."
About ClearTrial®
ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, an integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information visit http://www.cleartrial.com.
ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.
For more information contact:
Mike Lange
ClearTrial
+1 312.460.3015
mlange@cleartrial.com |
